Calbeta is a fixed-dose combination tablet that combines Cilnidipine, a calcium channel blocker, and Metoprolol Succinate, a cardioselective beta-blocker. This dual-action antihypertensive medication provides effective and long-lasting control of high blood pressure, while reducing the risk of heart-related complications such as angina and heart failure.